Activity Description:

This learning activity will review the incidence of leiomyomas; diagnosis including review of clinical symptoms and imaging; risks for chronic complications, acute complications leading to emergency room visit and emergency treatments. Presentation of available options for treatment including hormonal management, management of complications (hemorrhage), surgical management (myomectomy, hysterectomy, radiofrequency ablation of leiomyomas), uterine artery embolization by interventional radiology. Additionally, there will be discussion of the optimal choices for management depending on the characteristics of the fibroid, patient's age, fertility, associated comorbidities, acute complications.

Target Audience: 

This course is designed for hospitalists, nurse practitioners, physician assistants, advance practice nurses, registered nurses, allied health professionals, physicians and residents.

Learning Objectives:

• Identify uterine leiomyomas and the magnitude of the problem.
• Assess diagnosis and the potential complications related to different types of leiomyomas.
• Evaluate different options for management; individualize and tailor the options for management based on pathology, patient’s preference and potential for complications if left untreated.

Moderator:

Speaker: Victor Dabelea, MD

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.